Literature DB >> 23892662

A new player SETs in myeloid malignancy.

Thomas Trimarchi, Panagiotis Ntziachristos, Iannis Aifantis.   

Abstract

Recent studies have identified recurrent mutations in SETBP1, the gene that encodes SET-binding protein 1, in several types of myeloid malignancies, including chronic myeloid and acute myeloid leukemias. The identified mutations frequently target the SKI-homologous domain, although the exact pathogenic mechanisms remain unknown.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23892662      PMCID： PMC4310681          DOI： 10.1038/ng.2709

Source DB:  PubMed          Journal:  Nat Genet        ISSN： 1061-4036            Impact factor:   38.330


  12 in total

1.  Hematologic malignancies.

Authors:  D G Gilliland
Journal:  Curr Opin Hematol       Date:  2001-07       Impact factor: 3.284

2.  De novo mutations of SETBP1 cause Schinzel-Giedion syndrome.

Authors:  Alexander Hoischen; Bregje W M van Bon; Christian Gilissen; Peer Arts; Bart van Lier; Marloes Steehouwer; Petra de Vries; Rick de Reuver; Nienke Wieskamp; Geert Mortier; Koen Devriendt; Marta Z Amorim; Nicole Revencu; Alexa Kidd; Mafalda Barbosa; Anne Turner; Janine Smith; Christina Oley; Alex Henderson; Ian M Hayes; Elizabeth M Thompson; Han G Brunner; Bert B A de Vries; Joris A Veltman
Journal:  Nat Genet       Date:  2010-05-02       Impact factor: 38.330

3.  SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias.

Authors:  F Damm; R Itzykson; O Kosmider; N Droin; A Renneville; V Chesnais; V Gelsi-Boyer; S de Botton; N Vey; C Preudhomme; A Clavert; E Delabesse; S Park; D Birnbaum; M Fontenay; O A Bernard; E Solary
Journal:  Leukemia       Date:  2013-02-05       Impact factor: 11.528

4.  Identification and characterization of SEB, a novel protein that binds to the acute undifferentiated leukemia-associated protein SET.

Authors:  M Minakuchi; N Kakazu; M J Gorrin-Rivas; T Abe; T D Copeland; K Ueda; Y Adachi
Journal:  Eur J Biochem       Date:  2001-03

5.  The myeloid leukemia-associated protein SET is a potent inhibitor of protein phosphatase 2A.

Authors:  M Li; A Makkinje; Z Damuni
Journal:  J Biol Chem       Date:  1996-05-10       Impact factor: 5.157

6.  Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia.

Authors:  Hirotoshi Sakaguchi; Yusuke Okuno; Hideki Muramatsu; Kenichi Yoshida; Yuichi Shiraishi; Mariko Takahashi; Ayana Kon; Masashi Sanada; Kenichi Chiba; Hiroko Tanaka; Hideki Makishima; Xinan Wang; Yinyan Xu; Sayoko Doisaki; Asahito Hama; Koji Nakanishi; Yoshiyuki Takahashi; Nao Yoshida; Jaroslaw P Maciejewski; Satoru Miyano; Seishi Ogawa; Seiji Kojima
Journal:  Nat Genet       Date:  2013-07-07       Impact factor: 38.330

Review 7.  The role of mutations in epigenetic regulators in myeloid malignancies.

Authors:  Alan H Shih; Omar Abdel-Wahab; Jay P Patel; Ross L Levine
Journal:  Nat Rev Cancer       Date:  2012-08-17       Impact factor: 60.716

8.  Fusion of NUP98 and the SET binding protein 1 (SETBP1) gene in a paediatric acute T cell lymphoblastic leukaemia with t(11;18)(p15;q12).

Authors:  Ioannis Panagopoulos; Gitte Kerndrup; Niels Carlsen; Bodil Strömbeck; Margareth Isaksson; Bertil Johansson
Journal:  Br J Haematol       Date:  2007-01       Impact factor: 6.998

9.  Recurrent SETBP1 mutations in atypical chronic myeloid leukemia.

Authors:  Rocco Piazza; Simona Valletta; Nils Winkelmann; Sara Redaelli; Roberta Spinelli; Alessandra Pirola; Laura Antolini; Luca Mologni; Carla Donadoni; Elli Papaemmanuil; Susanne Schnittger; Dong-Wook Kim; Jacqueline Boultwood; Fabio Rossi; Giuseppe Gaipa; Greta P De Martini; Paola Francia di Celle; Hyun Gyung Jang; Valeria Fantin; Graham R Bignell; Vera Magistroni; Torsten Haferlach; Enrico Maria Pogliani; Peter J Campbell; Andrew J Chase; William J Tapper; Nicholas C P Cross; Carlo Gambacorti-Passerini
Journal:  Nat Genet       Date:  2012-12-09       Impact factor: 38.330

10.  Somatic SETBP1 mutations in myeloid malignancies.

Authors:  Hideki Makishima; Kenichi Yoshida; Nhu Nguyen; Bartlomiej Przychodzen; Masashi Sanada; Yusuke Okuno; Kwok Peng Ng; Kristbjorn O Gudmundsson; Bandana A Vishwakarma; Andres Jerez; Ines Gomez-Segui; Mariko Takahashi; Yuichi Shiraishi; Yasunobu Nagata; Kathryn Guinta; Hiraku Mori; Mikkael A Sekeres; Kenichi Chiba; Hiroko Tanaka; Hideki Muramatsu; Hirotoshi Sakaguchi; Ronald L Paquette; Michael A McDevitt; Seiji Kojima; Yogen Saunthararajah; Satoru Miyano; Lee-Yung Shih; Yang Du; Seishi Ogawa; Jaroslaw P Maciejewski
Journal:  Nat Genet       Date:  2013-07-07       Impact factor: 38.330
View more
  9 in total

1.  An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms.

Authors:  Tariq I Mughal; Nicholas C P Cross; Eric Padron; Ramon V Tiu; Michael Savona; Luca Malcovati; Raoul Tibes; Rami S Komrokji; Jean-Jacques Kiladjian; Guillermo Garcia-Manero; Attilio Orazi; Ruben Mesa; Jaroslaw P Maciejewski; Pierre Fenaux; Raphael Itzykson; Ghulam Mufti; Eric Solary; Alan F List
Journal:  Haematologica       Date:  2015-09       Impact factor: 9.941

Review 2.  The genetic basis of myelodysplasia and its clinical relevance.

Authors:  Mario Cazzola; Matteo G Della Porta; Luca Malcovati
Journal:  Blood       Date:  2013-10-17       Impact factor: 22.113

3.  A novel mutation of SETBP1 in atypical chronic myeloid leukemia transformed from acute myelomonocytic leukemia.

Authors:  WangQiang Hu; XiaoXia Wang; RongRong Yang; YaoSheng Xie; Zhuo Zhang; Hong Lu; LianFeng Wu; MeiMei Lai; Kang Yu
Journal:  Clin Case Rep       Date:  2015-04-22

4.  The recurrent chromosomal translocation t(12;18)(q14~15;q12~21) causes the fusion gene HMGA2-SETBP1 and HMGA2 expression in lipoma and osteochondrolipoma.

Authors:  Ioannis Panagopoulos; Ludmila Gorunova; Bodil Bjerkehagen; Ingvild Lobmaier; Sverre Heim
Journal:  Int J Oncol       Date:  2015-07-21       Impact factor: 5.650

5.  A novel insertion ins(18;5)(q21.1;q31.2q35.1) in acute myeloid leukemia associated with microdeletions at 5q31.2, 5q35.1q35.2 and 18q12.3q21.1 detected by oligobased array comparative genomic hybridization.

Authors:  Eigil Kjeldsen
Journal:  Mol Cytogenet       Date:  2014-09-25       Impact factor: 2.009

6.  Mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia: a report from the Italian AIEOP study group.

Authors:  Silvia Bresolin; Paola De Filippi; Francesca Vendemini; Mirko D'Alia; Marco Zecca; Lueder H Meyer; Cesare Danesino; Franco Locatelli; Riccardo Masetti; Giuseppe Basso; Geertruy Te Kronnie
Journal:  Oncotarget       Date:  2016-05-17

7.  Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer.

Authors:  Cheng Zhang; Mengqi Zhang; Sai Ge; Wenwen Huang; Xiaoting Lin; Jing Gao; Jifang Gong; Lin Shen
Journal:  Cancer Med       Date:  2019-06-26       Impact factor: 4.452

8.  Cell cycle, oncogenic and tumor suppressor pathways regulate numerous long and macro non-protein-coding RNAs.

Authors:  Jörg Hackermüller; Kristin Reiche; Christian Otto; Nadine Hösler; Conny Blumert; Katja Brocke-Heidrich; Levin Böhlig; Anne Nitsche; Katharina Kasack; Peter Ahnert; Wolfgang Krupp; Kurt Engeland; Peter F Stadler; Friedemann Horn
Journal:  Genome Biol       Date:  2014-03-04       Impact factor: 13.583

9.  ASXL1 and SETBP1 mutations promote leukaemogenesis by repressing TGFβ pathway genes through histone deacetylation.

Authors:  Makoto Saika; Daichi Inoue; Reina Nagase; Naru Sato; Akiho Tsuchiya; Tomohiro Yabushita; Toshio Kitamura; Susumu Goyama
Journal:  Sci Rep       Date:  2018-10-26       Impact factor: 4.379
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.